Lei et al. demonstrated that EMR1/ADGRE1 expression in cancer exhibited a positive correlation with immune cell infiltration in uterine corpus endometrial carcinoma [31]. This evidence concerns the gene ADGRE1 and uterine corpus endometrial carcinoma.